| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.009 |